Distinctive Flow Cytometric and Mutational Profile of Acute Myeloid Leukemia With t(8;16)(p11;p13) Translocation. Issue 5 (26th October 2021)

• Record Type: Journal Article
• Authors: Aqil, Barina; Gao, Juehua; Stalling, Melissa; Sukhanova, Madina; Duncavage, Eric J; Lu, Xinyan; Wolniak, Kristy L; Kreisel, Friederike; Yaseen, Nabeel R
• Is Part Of: American journal of clinical pathology. Volume 157:Issue 5(2022)
• Page Start: 701
• Page End: 708
• Publication Date: 2021-10-26
• Subjects: AML -- t(8; 16) -- Myelomonocytic -- Genomic profile -- Flow cytometry; Diagnosis, Laboratory -- Periodicals; Pathology -- Periodicals; 616.07
• DOI: 10.1093/ajcp/aqab178
• Languages: English
• ISSNs: 0002-9173

Abstract

Abstract: Objectives: Acute myeloid leukemia (AML) with t(8;16)(p11;p13) abnormalities is a rare, aggressive, and diagnostically challenging subtype that results in KAT6A-CREBBP gene fusion. Methods: To investigate their immunophenotype and genomic features, we identified 5 cases of AML with t(8;16) through a retrospective review of the databases at Northwestern Memorial Hospital in Chicago, IL, and Washington University Medical Center, in St Louis, MO. Results: In all, 4 of 5 cases were therapy related and 1 was possibly therapy related. The leukemic blasts showed distinctive features, including bright CD45 expression and remarkably high side scatter that overlapped with maturing myeloid elements, making the blasts difficult to identify on initial examination. They were positive for CD13, CD33, and CD64 and negative for CD34 and CD117. Next-generation sequencing profiling of 4 cases revealed pathogenic ASXL1 (2 cases), FLT3 -tyrosine kinase domain (TKD) mutations (2 cases), and other pathogenic mutations. In 3 patients, t(8;16) was the sole cytogenetic abnormality; additional aberrations were found in 2 patients. Single nucleotide polymorphism microarray revealed 1 case with 7q deletion as a secondary clone. Conclusions: Our data highlight the distinctive immunophenotypic profile of AML with t(8;16), which, along with its unique morphology, often presents a diagnostic challenge. We showed that mutations of either ASXL1 or FLT3 -TKD are seen in most cases of this leukemia.